QUIDELORTHO DL-001
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laborator… Read more
QUIDELORTHO DL-001 (QL1A) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, QUIDELORTHO DL-001 (QL1A) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
QUIDELORTHO DL-001 - Net Assets Trend (None–None)
This chart illustrates how QUIDELORTHO DL-001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for QUIDELORTHO DL-001 (None–None)
The table below shows the annual net assets of QUIDELORTHO DL-001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to QUIDELORTHO DL-001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
QUIDELORTHO DL-001 Competitors by Market Cap
The table below lists competitors of QUIDELORTHO DL-001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ST Pharm Co.Ltd
KQ:237690
|
$1.05 Billion |
|
PDF Solutions Inc
NASDAQ:PDFS
|
$1.05 Billion |
|
Faes Farma SA
MC:FAE
|
$1.05 Billion |
|
Bittium Oyj
HE:BITTI
|
$1.05 Billion |
|
L&T Technology Services Limited
NSE:LTTS
|
$1.05 Billion |
|
Mercialys SA
PA:MERY
|
$1.05 Billion |
|
Deutsche Wohnen AG
LSE:0OBQ
|
$1.05 Billion |
|
MIRAIT ONE Corporation
PINK:MRHLF
|
$1.05 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in QUIDELORTHO DL-001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares QUIDELORTHO DL-001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently QUIDELORTHO DL-001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares QUIDELORTHO DL-001's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| QUIDELORTHO DL-001 (QL1A) | €- | N/A | N/A | $1.05 Billion |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |